Surfactant protein A and surfactant protein D in health and disease

被引:159
作者
Mason, RJ
Greene, K
Voelker, DR
机构
[1] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Biochem, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
关键词
host defense; lung injury; alveolar type II cells; collectins;
D O I
10.1152/ajplung.1998.275.1.L1
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Surfactant protein (SP) A and SP-D are collagenous glycoproteins with multiple functions in the lung. Both of these proteins are calcium-dependent lectins and are structurally similar to mannose-binding protein and bovine conglutinin. Both form polyvalent multimeric structures for interactions with pathogens, cells, or other molecules. SP-A is an integral part of the surfactant system, binds phospholipids avidly, and is found in lamellar bodies and tubular myelin. Initially, most research interest focused on its role in surfactant homeostasis. Recently, more attention has been placed on the role of SP-A as a host defense molecule and its interactions with pathogens and phagocytic cells. SP-D is much less involved with the surfactant system. SP-D appears to be primarily a host defense molecule that binds surfactant phospholipids poorly and is not found in lamellar inclusion bodies or tubular myelin. Both SP-A and SP-D bind a wide spectrum of pathogens including viruses, bacteria, fungi, and pneumocystis. In addition, both molecules have been measured in the systemic circulation by immunologic methods and may be useful biomarkers of disease. The current challenges are characterization of the three-dimensional crystal structure of SP-A and SP-D, molecular cloning of their receptors, and determination of their precise physiological functions in vivo.
引用
收藏
页码:L1 / L13
页数:13
相关论文
共 112 条
  • [11] DRICKAMER K, 1986, J BIOL CHEM, V261, P6878
  • [12] Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus
    Eda, S
    Suzuki, Y
    Kawai, T
    Ohtani, K
    Kase, T
    Fujinaga, Y
    Sakamoto, T
    Kurimura, T
    Wakamiya, N
    [J]. BIOCHEMICAL JOURNAL, 1997, 323 : 393 - 399
  • [13] Alternate amino terminal processing of surfactant protein A results in cysteinyl isoforms required for multimer formation
    Elhalwagi, BM
    Damodarasamy, M
    McCormack, FX
    [J]. BIOCHEMISTRY, 1997, 36 (23) : 7018 - 7025
  • [14] INHIBITION OF LUNG CALCIUM-INDEPENDENT PHOSPHOLIPASE A(2) BY SURFACTANT PROTEIN-A
    FISHER, AB
    DODIA, C
    CHANDER, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03): : L335 - L341
  • [15] GAYNOR CD, 1995, J IMMUNOL, V155, P5343
  • [16] GREENE KE, 1997, AM J RESP CRIT CARE, V155, pA216
  • [17] SURFACTANT CHEMICAL-COMPOSITION AND BIOPHYSICAL ACTIVITY IN ACUTE RESPIRATORY-DISTRESS SYNDROME
    GREGORY, TJ
    LONGMORE, WJ
    MOXLEY, MA
    WHITSETT, JA
    REED, CR
    FOWLER, AA
    HUDSON, LD
    MAUNDER, RJ
    CRIM, C
    HYERS, TM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) : 1976 - 1981
  • [18] Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-a
    Guay, LA
    SierraMadero, JG
    Finegan, CK
    Rich, EA
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (04) : 421 - 428
  • [19] HAAGSMAN HP, 1993, SOC T, V22, P100
  • [20] ELEVATED SURFACTANT PROTEIN-A IN BRONCHOALVEOLAR LAVAGE FLUIDS FROM SARCOIDOSIS AND HYPERSENSITIVITY PNEUMONITIS PATIENTS
    HAMM, H
    LUHRS, J
    ROTAECHE, JGY
    COSTABEL, U
    FABEL, H
    BARTSCH, W
    [J]. CHEST, 1994, 106 (06) : 1766 - 1770